Search Products
Hot Products
Gynecology & Obstetrics - ROM
AmniSure
  • ROM Test
  • AmniSure® is a rapid, non-invasive test that aids in the detection of ROM in pregnant women with signs and symptoms suggestive of the condition. It provides an easy-to-interpret, accurate, and timely diagnosis that enables clinicians to take opportune measures to prevent complications.

    The AmniSure® test does not require a speculum examination. The sample is taken by sterile swab, which is inserted only 2-3 inches deep (5-7 cm) into the vagina. A clear “Yes/No” result can be read in minutes.

    - The first FDA cleared test for the diagnosis of Rupture of Membrane (ROM)
    - Quick and easy rapid test that detects Placental Alpha Microglobulin-1 (PAMG-1) protein
    - Placental alpha microglobulin-1 (PAMG-1) is present in the blood, amniotic fluid and cervico-vaginal discharge of pregnant women
    - The concentration is several thousand magnitudes higher than that which is found in vaginal discharge in pregnant women when the fetal membrane is intact

PartoSure
  • Portosure
  • Parsagen Diagnostics, the makers of PartoSure, is an early-stage medical device company focused on Women’s Health that is based in the Boston, Massachusetts area. The company’s founders are an experienced team composed of industry leaders with successful track records for developing medical devices from concept through commercialization.

    The PartoSure™ TTD Test is a rapid bedside test that aids in the prediction of time to delivery. The test is indicated for patients presenting at 20 to 36⁶⁄₇ weeks gestational age with:

    - Signs and symptoms of early preterm labour
    - Intact amniotic membranes
    - Minimal cervical dilatation (≤ 3 cm)
    - Between 20 weeks, 0 days and 36 weeks, 6 days gestation

    The PartoSure™ TTD Test detects placental alpha- microglobulin-1 (PAMG-1), a protein found in very high concentrations in amniotic fluid and in very low concentrations in normal vaginal discharge. Recent clinical studies have demonstrated a strong correlation between a positive PAMG-1 test and imminent delivery in those patients presenting with threatened preterm labour and clinically intact membranes.

Gynecology & Obstetrics - Pessaries
Dr.Arabin GmbH & Co.
EPISCISSORS-60™

EPISCISSORS-60™ have a unique patented form and design. They have a guide-limb that points towards the anus and is in the vertical plane. The scissors blades constantly maintain a 60 degree angle from the guide-limb. The flexible nature of the guide accommodates the spherical distention at crowning.

Eyeballing a sphere

What is the evidence for EPISCISSORS-60™?

Four clinical studies have been done using the EPISCISSORS-60 showing episiotomy suture angles between 40-52 degrees [6-8]. The suture angle will depend on how distended the perineum is when the episiotomy is given. The more distended the perineum, the lesser the post-delivery angle.

A 2-centre UK study has shown a 20% reduction in OASIS due to adoption of the EPISCISSORS-60™ [van Roon 2015].

 
Gynecology & Obstetrics - First Trimester Screening
Neobona
Why choose neoBona?

What is neoBona?. The new generation of Non-Invasive Prenatal test

  • - RELIABLE Thanks to the cutting edge technology
  • - FAST Results available in one week
  • - ACCURATE Sensitivity higher than 99% for Down’s Syndrome
  • - SAFE Non-invasive for the fetus
  • - SIMPLE A single blood test from the mother
  • - EXPERIENCE A reliable and trusted pioneer and leader in diagnostics
 
 
PELICAN
Why choose neoBona?

Pelican Feminine Healthcare Ltd is a UK manufacturer of single-use medical instruments for Gynaecology and Obstetrics, including the market leading PELIspec® vaginal speculum.

State-of-the-art manufacturing facilities and active research and development highlight Pelican Feminine Healthcare’s commitment to the continuous development of innovative healthcare solutions in Women’s health.